gemcitabine has been researched along with knk 437 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuramitsu, Y; Maehara, S; Maehara, Y; Mori-Iwamoto, S; Nakamura, K; Ryozawa, S; Sakaida, I; Taba, K; Tanaka, T; Yoshida, K | 1 |
1 other study(ies) available for gemcitabine and knk 437
| Article | Year |
|---|---|
KNK437 downregulates heat shock protein 27 of pancreatic cancer cells and enhances the cytotoxic effect of gemcitabine.
Topics: Antimetabolites, Antineoplastic; Benzhydryl Compounds; Deoxycytidine; Down-Regulation; Gemcitabine; HSP27 Heat-Shock Proteins; Humans; Pancreatic Neoplasms; Pyrrolidinones; Tumor Cells, Cultured | 2011 |